WESPAC Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,220
Closed -$202K 146
2023
Q2
$202K Buy
+1,220
New +$197K 0.16% 120
2023
Q1
Sell
-3,607
Closed -$637K 117
2022
Q4
$637K Sell
3,607
-537
-13% -$92.7K 1.1% 30
2022
Q3
$677K Sell
4,144
-581
-12% -$98.3K 0.91% 42
2022
Q2
$839K Buy
+4,725
New +$842K 0.64% 44
2019
Q2
Sell
-1,974
Closed -$270K 131
2019
Q1
$270K Buy
+1,974
New +$264K 0.19% 99
2018
Q4
Sell
-1,506
Closed -$208K 145
2018
Q3
$208K Buy
+1,506
New +$200K 0.12% 137
2018
Q1
Sell
-4,075
Closed -$569K 158
2017
Q4
$569K Sell
4,075
-2,831
-41% -$394K 0.53% 63
2017
Q3
$898K Buy
6,906
+287
+4% +$38K 0.59% 52
2017
Q2
$876K Buy
6,619
+1,867
+39% +$238K 0.6% 54
2017
Q1
$592K Buy
4,752
+2,294
+93% +$274K 0.68% 55
2016
Q4
$283K Sell
2,458
-3,150
-56% -$364K 0.32% 89
2016
Q3
$662K Sell
5,608
-3,191
-36% -$387K 0.75% 51
2016
Q2
$1.07M Buy
8,799
+989
+13% +$112K 1.1% 36
2016
Q1
$845K Buy
7,810
+5,359
+219% +$555K 1.05% 45
2015
Q4
$252K Buy
+2,451
New +$246K 0.29% 79
2015
Q3
Sell
-2,657
Closed -$259K 91
2015
Q2
$259K Sell
2,657
-953
-26% -$95.4K 0.19% 96
2015
Q1
$363K Buy
+3,610
New +$367K 0.28% 93
2014
Q4
Sell
-3,503
Closed -$373K 141
2014
Q3
$373K Buy
+3,503
New +$363K 0.3% 95
2014
Q2
Sell
-2,730
Closed -$268K 123
2014
Q1
$268K Hold
2,730
0.23% 109
2013
Q4
$250K Buy
+2,730
New +$252K 0.21% 118

Other funds holding JNJ

WESPAC Advisors's JNJ Position: Q3 2023 in Review

WESPAC Advisors sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 1,220 shares — an estimated $202K sold.

WESPAC Advisors first reported a position in JNJ in Q4 2013 and held it in 20 quarters. The position peaked at $1.07M in Q2 2016. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • WESPAC Advisors reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • WESPAC Advisors sold 1,220 Johnson & Johnson shares in Q3 2023, an estimated $202K.
  • WESPAC Advisors first reported a position in Johnson & Johnson in Q4 2013 and held it in 20 quarters.
  • WESPAC Advisors's Johnson & Johnson position peaked at $1.07M in Q2 2016.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on WESPAC Advisors's 13F filing for Q3 2023, filed 26 Oct 2023.